Keytruda with Padcev improves survival of cisplatin-eligible patients with MIBC
KEYNOTE-B15, also known as EV-304, is an open-label, randomized Phase 3 trial evaluating perioperative KEYTRUDA in combination with Padcev and surgery (radical cystectomy and pelvic lymph node dissection) versus neoadjuvant chemotherapy and surgery in patients with MIBC who are cisplatin-eligible.

















Vinay Kumar Singh. 


